Please enable JavaScript.
Coggle requires JavaScript to display documents.
Dr Reddys laboratories - Coggle Diagram
Dr Reddys laboratories
Value creation in the future
Focus on sustainability
Becoming a water positive company by 2025
Transition to 100% renewable power by 2025
Enhancing ESG disclosures to reach top quartile by 2025
Strategic acquistions
Aqcuring minority stake in Cipla limited through a consortium led by the company
Pateint centric approach
Affordability
Planning to serve 1.5 billion pateients by 2030
Innovation
Planning to launch three innovative solutions every year
Improving the standard of treatment
Acess
Targeting 25% of new launches to be first to be market by 2027
work culture
Inclusion
include at least 3% Persons with
Disabilities (PwDs) in our workforce by 2030
Equity
Ensuring living wages for the extended
workforce on our premises
Diversity
Aiming to acheive gender parity across the organization by 2035
Corporate governance
Excellence
Fostering an environment of transparency and responsibility
Tax transparency
Anti trust and competition law
Human rights
Responsible product use
Educating clinical pharmacies through regular meetings and update
Future market expectations
Oncology department is expected to grow at 13-16% CAGR
Global medicine market expected to grow at CAGR 3-6% by 2027
Value creation in the past
Work culture
83% employee engagement score
1.25% increase of women in the workforce
to 18.33%
Fousing on innovation
163 new products launched in the pharamaseutical sector
₹19,381 million spent on R&D
Strong brand building
Recognised amongst Top 20 Employers
in pharma/biotech globally by Science Magazine
Recognised by the President of India forempowering Persons with Disabilities through Dr. Reddy’s Foundation
Financial reporting
Profitable growth for shareholders
ICAI Awards for Excellence in Financial
Reporting for 2021-2022
Pateint centric approach
Introduction of Sparsh which is a Financial assistance program for underprivileged cancer patients
46,000 Stakeholders had trained to deliver better patient outcomes
Efficent operations
Factory of future initiative-integartion of five pillar approach which uses lean principles
Ops next programme Implementation of 40 industry 4.0 initiatives
30% reduction in production lead time
43% improvement in manufacturing costs
Corporate governance
98% avergae attendance in board and committee meetings
No material deviations in complaince and ethics